Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.

López-Nieva P, Fernández-Navarro P, Vaquero-Lorenzo C, Villa-Morales M, Graña-Castro O, Cobos-Fernández MÁ, López-Lorenzo JL, Llamas P, González-Sanchez L, Sastre I, Pollan M, Malumbres M, Santos J, Fernández-Piqueras J.

BMC Cancer. 2018 Apr 16;18(1):430. doi: 10.1186/s12885-018-4304-y.

2.

Innate Immune Response and Off-Target Mis-splicing Are Common Morpholino-Induced Side Effects in Xenopus.

Gentsch GE, Spruce T, Monteiro RS, Owens NDL, Martin SR, Smith JC.

Dev Cell. 2018 Mar 12;44(5):597-610.e10. doi: 10.1016/j.devcel.2018.01.022. Epub 2018 Feb 22.

3.

p53 isoforms regulate premature aging in human cells.

von Muhlinen N, Horikawa I, Alam F, Isogaya K, Lissa D, Vojtesek B, Lane DP, Harris CC.

Oncogene. 2018 May;37(18):2379-2393. doi: 10.1038/s41388-017-0101-3. Epub 2018 Feb 12.

PMID:
29429991
4.

The interplay of UV and cutaneous papillomavirus infection in skin cancer development.

Hasche D, Stephan S, Braspenning-Wesch I, Mikulec J, Niebler M, Gröne HJ, Flechtenmacher C, Akgül B, Rösl F, Vinzón SE.

PLoS Pathog. 2017 Nov 30;13(11):e1006723. doi: 10.1371/journal.ppat.1006723. eCollection 2017 Nov.

5.

MGMT promoter methylation as a potential prognostic marker for acute leukemia.

Sobieszkoda D, Czech J, Gablo N, Kopanska M, Tabarkiewicz J, Kolacinska A, Robak T, Zawlik I.

Arch Med Sci. 2017 Oct;13(6):1433-1441. doi: 10.5114/aoms.2017.71067. Epub 2017 Oct 31.

6.

Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.

Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, Desgrandschamps F, Carosella ED.

Mol Oncol. 2017 Nov;11(11):1561-1578. doi: 10.1002/1878-0261.12119. Epub 2017 Sep 13.

7.

Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.

Lakatos E, Salehi-Reyhani A, Barclay M, Stumpf MPH, Klug DR.

PLoS One. 2017 May 10;12(5):e0177336. doi: 10.1371/journal.pone.0177336. eCollection 2017.

8.

Y14 governs p53 expression and modulates DNA damage sensitivity.

Lu CC, Lee CC, Tseng CT, Tarn WY.

Sci Rep. 2017 Mar 31;7:45558. doi: 10.1038/srep45558.

9.

Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response.

Li H, Wang S, Chen Y, Lǚ K, Yin B, Li S, He J, Li C.

Sci Rep. 2017 Mar 31;7:45821. doi: 10.1038/srep45821.

10.

The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.

Arsic N, Ho-Pun-Cheung A, Evelyne C, Assenat E, Jarlier M, Anguille C, Colard M, Pezet M, Roux P, Gadea G.

PLoS One. 2017 Feb 17;12(2):e0172125. doi: 10.1371/journal.pone.0172125. eCollection 2017. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175607.

11.

Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.

Olivos DJ, Mayo LD.

Int J Mol Sci. 2016 Nov 26;17(12). pii: E1982. Review.

12.
13.

TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants.

Sulak M, Fong L, Mika K, Chigurupati S, Yon L, Mongan NP, Emes RD, Lynch VJ.

Elife. 2016 Sep 19;5. pii: e11994. doi: 10.7554/eLife.11994. Erratum in: Elife. 2016 Dec 20;5:.

14.

Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha.

Hasche D, Stephan S, Savelyeva L, Westermann F, Rösl F, Vinzón SE.

PLoS One. 2016 Aug 17;11(8):e0161283. doi: 10.1371/journal.pone.0161283. eCollection 2016.

15.

Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Kehrloesser S, Osterburg C, Tuppi M, Schäfer B, Vousden KH, Dötsch V.

Cell Death Differ. 2016 Dec;23(12):1952-1960. doi: 10.1038/cdd.2016.75. Epub 2016 Jul 22.

16.

Role of p53 isoforms and aggregations in cancer.

Kim S, An SS.

Medicine (Baltimore). 2016 Jun;95(26):e3993. doi: 10.1097/MD.0000000000003993. Review.

17.

Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics.

Pomo JM, Taylor RM, Gullapalli RR.

Cancer Cell Int. 2016 Jun 13;16:44. doi: 10.1186/s12935-016-0318-1. eCollection 2016.

18.

Oncogenic Intra-p53 Family Member Interactions in Human Cancers.

Ferraiuolo M, Di Agostino S, Blandino G, Strano S.

Front Oncol. 2016 Mar 31;6:77. doi: 10.3389/fonc.2016.00077. eCollection 2016. Review.

19.

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients.

Trino S, Iacobucci I, Erriquez D, Laurenzana I, De Luca L, Ferrari A, Ghelli Luserna Di Rorà A, Papayannidis C, Derenzini E, Simonetti G, Lonetti A, Venturi C, Cattina F, Ottaviani E, Abbenante MC, Russo D, Perini G, Musto P, Martinelli G.

Oncotarget. 2016 Mar 15;7(11):12951-61. doi: 10.18632/oncotarget.7339.

20.

Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.

Bazrafshani MR, Nowshadi PA, Shirian S, Daneshbod Y, Nabipour F, Mokhtari M, Hosseini F, Dehghan S, Saeedzadeh A, Mosayebi Z.

Cancer Med. 2016 Feb;5(2):145-52. doi: 10.1002/cam4.561. Epub 2015 Dec 21.

Supplemental Content

Support Center